Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer

Epidermal growth factor receptor (EGFR) is extensively expressed in head and neck cancer. However, EGFR-targeted therapy has only modest efficacy in head and neck cancer, through mechanisms that are not fully understood. Here, we found that inhibition of EGFR by erlotinib stimulated phosphorylation...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Li, Rui, You, Shuo, Hu, Zhongliang, Chen, Zhuo G., Sica, Gabriel L., Khuri, Fadlo R., Curran, Walter J., Shin, Dong M., Deng, Xingming
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3760825/
https://ncbi.nlm.nih.gov/pubmed/24019973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0074670
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi